NEW YORK (GenomeWeb News) – Everist Genomics today said that it will open a lab within Johnson & Johnson's Janssen Labs innovation center in San Diego.
The Ann Arbor, Mich.-based personalized medicine technologies firm said that it is one of only 15 firms that have been selected to date by J&J to set up a lab at the innovation center, which was launched in January 2012. It intends to open the lab in the third quarter of this year, enabling the firm to realize cost efficiencies from sharing resources with other firms that set up labs at Janssen Labs.
J&J launched Janssen Labs in January. It is located in the company's Janssen West Coast Research Center and provides smaller firms with research space, equipment, and access to core labs. Companies that set up a lab at the innovation center are not obligated to collaborate with J&J and the firm does not receive an equity stake in the firms that set up shop there.
"The expansion of EGI into Janssen Labs represents an exciting opportunity for us to showcase the unique capabilities of our diagnostics, prognostics, and therapeutic selection technologies," Alex Charlton, executive vice chairman of Everist Genomics, said in a statement. "Ultimately, we expect this initiative to support our entire business strategy, from new product development to marketing and sales, catalyzing both short-term and long-term growth opportunities."
Everist launched its first product, the OncoDefender-CRC companion diagnostic test, a year ago and has since launched three other cancer companion diagnostic tests. It also has entered the cardiovascular space with mobile monitoring devices.